BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16343224)

  • 1. Response of recurrent uterine high-grade malignant mixed müllerian tumor to letrozole.
    Wang X; Tangjitgamol S; Liu J; Kavanagh JJ
    Int J Gynecol Cancer; 2005; 15(6):1243-8. PubMed ID: 16343224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole.
    Leunen M; Breugelmans M; De Sutter P; Bourgain C; Amy JJ
    Gynecol Oncol; 2004 Dec; 95(3):769-71. PubMed ID: 15582003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine malignant mixed Müllerian tumor after adjuvant tamoxifen treatment for breast cancer.
    Grigoriadis C; Androutsopoulos G; Zygouris D; Arnogiannaki N; Terzakis E
    Eur J Gynaecol Oncol; 2013; 34(1):94-8. PubMed ID: 23590011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique case of malignant mixed müllerian tumor with metastasis to the thyroid: a case report.
    Herbas OC; Garcia-Prieto BE; Fulger I
    Tumori; 2017 Nov; 103(Suppl. 1):e60-e61. PubMed ID: 28777428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
    Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
    Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
    Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
    Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial stromal sarcoma: objective response to letrozole.
    Maluf FC; Sabbatini P; Schwartz L; Xia J; Aghajanian C
    Gynecol Oncol; 2001 Aug; 82(2):384-8. PubMed ID: 11531300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant Mixed Müllerian Tumour of the Uterus: Analysis of 44 Cases.
    Grasso S; Loizzi V; Minicucci V; Resta L; Camporeale AL; Cicinelli E; Cormio G
    Oncology; 2017; 92(4):197-204. PubMed ID: 28092915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience.
    Hoskins PJ; Le N; Ellard S; Lee U; Martin LA; Swenerton KD; Tinker AV;
    Gynecol Oncol; 2008 Jan; 108(1):58-62. PubMed ID: 17935761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant mixed müllerian tumor of the uterine corpus--analysis of 12 cases.
    Huang KG; Chang TC; Lai CH; Hsueh S; Tseng CJ; Soong YK
    Changgeng Yi Xue Za Zhi; 1995 Mar; 18(1):27-35. PubMed ID: 7767851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): treatment with letrozole.
    Krauss K; Bachmann C; Hartmann JT; Siegmann K; Sotlar K; Wallwiener D; Huober J
    Anticancer Res; 2007; 27(5B):3477-80. PubMed ID: 17972504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous malignant mixed Müllerian tumor of the uterus with transitional cell carcinoma of the ovary.
    Sahai P; Kakkar A; Pathy S; Kumar L; Bhatla N; Chander S
    J Obstet Gynaecol Res; 2015 Feb; 41(2):319-23. PubMed ID: 25227514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durable complete remission with aromatase inhibitor therapy in a patient with metastatic uterine carcinosarcoma with poor performance status and coagulation disorders: a case report.
    Martin-Romano P; Jurado M; Idoate MA; Arbea L; Hernandez-Lizoain JL; Cano D; Paramo JA; Martin-Algarra S
    J Med Case Rep; 2017 Apr; 11(1):115. PubMed ID: 28424084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine Carcinosarcomas - Diagnosis and Management.
    Denschlag D; Ulrich UA
    Oncol Res Treat; 2018; 41(11):675-679. PubMed ID: 30317231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant mixed Müllerian tumor of the fallopian tube: a case report.
    Watanabe T; Sugino T; Furukawa S; Soeda S; Nishiyama H; Fujimori K
    Eur J Gynaecol Oncol; 2012; 33(2):223-6. PubMed ID: 22611970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant mixed müllerian tumor of the fallopian tube: report of two cases and review of literature.
    Shen YM; Xie YP; Xu L; Yang KX; Yu N; Yu Y; Wang JH
    Arch Gynecol Obstet; 2010 Jun; 281(6):1023-8. PubMed ID: 20033419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapeutic management of recurrent/metastatic uterine carcinosarcomas (malignant mixed mullerian tumors): time for a re-appraisal?
    Markman M
    J Cancer Res Clin Oncol; 2004 Nov; 130(11):645-8. PubMed ID: 15300428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collision of three histologically distinct endometrial cancers of the uterus.
    Jang KS; Lee WM; Kim YJ; Cho SH
    J Korean Med Sci; 2012 Jan; 27(1):89-92. PubMed ID: 22219620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant mixed mullerian tumor of the uterus in a patient taking raloxifene.
    Goldman NA; de Los Angeles MM; Jones JG; Goldberg GL
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1278-80. PubMed ID: 15863610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.